Oxford BioDynamics: 3Ds to Success
Oxford BioDynamics (LSE:OBD) is a 3D genomics company and provides updates on operations for FY September 2026 and on its strategy to generate revenue from Discovery, Development and Diagnostics. Its AI-powered 3D genomics discovery platform transforms standard and legacy whole genome sequencing datasets into discovery insights in hours rather than months. Around 4,200 of the […]
The post Oxford BioDynamics: 3Ds to Success appeared first on UK Investor Magazine.
